News in English
Enter any phrase or word you would like to search for and click .
PostNews: Press Release
Decision on rights issue for continued growth, establishment of sales organization and commercial break-through
The Board of directors of Phase Holographic Imaging PHI AB (publ) (”PHI”) has decided to conduct a rights issue of units, which is subject to approval on Extraordinary General Meeting, that can provide the company a total of SEK 64.6 million at the most prior to issuing costs.
Learn more …
PostNews: Press Release
PHI increase sales in fourth quarter, as well
PHI hereby announces that net sales during the fourth and final fiscal quarter of 2017/18 amounted to 2.2 (1.2) MSEK, resulting in that the company saleswise achieves its best quarter ever for the second consecutive quarter.
Learn more …
PostNews: Press Release
PHI and world-leading research institute evaluate quantitative imaging of living tumor cells
QIMR Berghofer Medical Research Institute in Brisbane and PHI have entered an evaluation agreement to explore the use of live cell time-lapse cytometry based on quantitative phase microscopy to determine the impact of hypoxic microenvironment on cellular motility and metastatic potential in solid cancers.
Learn more …
PostNews
Phase Holographic Imaging launches new website
Today Phase Holographic Imaging (PHI) launches a new website. The new website has been created to comprehensively provide extensive product information, as well as an introduction to the range of cell biology applications supported by the HoloMonitor® system.
Learn more …
PostNews: Press Release
University of California, San Francisco and Phase Holographic Imaging establish Center of Excellence
University of California, San Francisco (UCSF) and Phase Holographic Imaging (PHI) have agreed to expand their on-going collaboration and establish a regional Holographic Imaging Cytometry Center of Excellence, located at the UCSF Helen Diller Family Comprehensive Cancer Center.
Learn more …
PostNews: Press Release
Novel HoloMonitor method identifies tumor creating cancer cells
Using HoloMonitor®, researchers at Harvard Medical School and Boston Children’s Hospital have developed a novel non-invasive method for distinguishing between active and dormant cancer cells.
Learn more …